Financhill
Buy
65

WGS Quote, Financials, Valuation and Earnings

Last price:
$78.90
Seasonality move :
71.65%
Day range:
$77.83 - $81.81
52-week range:
$2.63 - $89.11
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
7.83x
P/B ratio:
10.63x
Volume:
431.2K
Avg. volume:
505.1K
1-year change:
2736.56%
Market cap:
$2.2B
Revenue:
$202.6M
EPS (TTM):
-$3.11

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
WGS
GeneDx Holdings
$80.2M $0.11 39.72% -86.89% $15.25
DRIO
DarioHealth
$7.4M -$0.16 104.95% -60.98% $3.50
FOXO
FOXO Technologies
-- -- -- -- --
OTRK
Ontrak
$3.1M -- -13% -- --
SPOK
Spok Holdings
$35.5M $0.24 4.56% 18.18% --
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
WGS
GeneDx Holdings
$79.14 $15.25 $2.2B -- $0.00 0% 7.83x
DRIO
DarioHealth
$0.89 $3.50 $30.5M -- $0.00 0% 1.39x
FOXO
FOXO Technologies
$0.31 -- $5.4M -- $0.00 0% 2.30x
OTRK
Ontrak
$1.84 -- $7.8M -- $0.00 0% 0.63x
SPOK
Spok Holdings
$16.03 -- $325M 21.96x $0.31 7.8% 2.38x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
WGS
GeneDx Holdings
20.28% -3.016 4.47% 2.00x
DRIO
DarioHealth
33.03% -0.172 82.25% 1.27x
FOXO
FOXO Technologies
224.55% 17.369 1241.69% 0.06x
OTRK
Ontrak
40.88% 4.339 95.85% 0.98x
SPOK
Spok Holdings
-- 0.549 -- 1.08x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
WGS
GeneDx Holdings
$47.8M -$7.8M -32.02% -38.37% -10.12% -$5M
DRIO
DarioHealth
$3.9M -$12M -49.97% -71.65% -162.06% -$7.4M
FOXO
FOXO Technologies
$655K -$1.1M -- -- -83.28% $576K
OTRK
Ontrak
$1.6M -$5.1M -149.3% -231.34% -198.72% -$1.4M
SPOK
Spok Holdings
$27.7M $5.3M 9.13% 9.13% 15.31% $10.3M

GeneDx Holdings vs. Competitors

  • Which has Higher Returns WGS or DRIO?

    DarioHealth has a net margin of -10.81% compared to GeneDx Holdings's net margin of -166.11%. GeneDx Holdings's return on equity of -38.37% beat DarioHealth's return on equity of -71.65%.

    Company Gross Margin Earnings Per Share Invested Capital
    WGS
    GeneDx Holdings
    62.22% -$0.31 $256.5M
    DRIO
    DarioHealth
    52.23% -$0.25 $87.4M
  • What do Analysts Say About WGS or DRIO?

    GeneDx Holdings has a consensus price target of $15.25, signalling upside risk potential of 2.14%. On the other hand DarioHealth has an analysts' consensus of $3.50 which suggests that it could grow by 291.11%. Given that DarioHealth has higher upside potential than GeneDx Holdings, analysts believe DarioHealth is more attractive than GeneDx Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    WGS
    GeneDx Holdings
    2 2 0
    DRIO
    DarioHealth
    3 0 0
  • Is WGS or DRIO More Risky?

    GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison DarioHealth has a beta of 1.395, suggesting its more volatile than the S&P 500 by 39.491%.

  • Which is a Better Dividend Stock WGS or DRIO?

    GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DarioHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings pays -- of its earnings as a dividend. DarioHealth pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WGS or DRIO?

    GeneDx Holdings quarterly revenues are $76.9M, which are larger than DarioHealth quarterly revenues of $7.4M. GeneDx Holdings's net income of -$8.3M is higher than DarioHealth's net income of -$12.3M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while DarioHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.83x versus 1.39x for DarioHealth. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WGS
    GeneDx Holdings
    7.83x -- $76.9M -$8.3M
    DRIO
    DarioHealth
    1.39x -- $7.4M -$12.3M
  • Which has Higher Returns WGS or FOXO?

    FOXO Technologies has a net margin of -10.81% compared to GeneDx Holdings's net margin of -162.71%. GeneDx Holdings's return on equity of -38.37% beat FOXO Technologies's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    WGS
    GeneDx Holdings
    62.22% -$0.31 $256.5M
    FOXO
    FOXO Technologies
    54.77% -$0.15 $14M
  • What do Analysts Say About WGS or FOXO?

    GeneDx Holdings has a consensus price target of $15.25, signalling upside risk potential of 2.14%. On the other hand FOXO Technologies has an analysts' consensus of -- which suggests that it could fall by --. Given that GeneDx Holdings has higher upside potential than FOXO Technologies, analysts believe GeneDx Holdings is more attractive than FOXO Technologies.

    Company Buy Ratings Hold Ratings Sell Ratings
    WGS
    GeneDx Holdings
    2 2 0
    FOXO
    FOXO Technologies
    0 0 0
  • Is WGS or FOXO More Risky?

    GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison FOXO Technologies has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock WGS or FOXO?

    GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. FOXO Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings pays -- of its earnings as a dividend. FOXO Technologies pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WGS or FOXO?

    GeneDx Holdings quarterly revenues are $76.9M, which are larger than FOXO Technologies quarterly revenues of $1.2M. GeneDx Holdings's net income of -$8.3M is lower than FOXO Technologies's net income of -$1.9M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while FOXO Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.83x versus 2.30x for FOXO Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WGS
    GeneDx Holdings
    7.83x -- $76.9M -$8.3M
    FOXO
    FOXO Technologies
    2.30x -- $1.2M -$1.9M
  • Which has Higher Returns WGS or OTRK?

    Ontrak has a net margin of -10.81% compared to GeneDx Holdings's net margin of -217.21%. GeneDx Holdings's return on equity of -38.37% beat Ontrak's return on equity of -231.34%.

    Company Gross Margin Earnings Per Share Invested Capital
    WGS
    GeneDx Holdings
    62.22% -$0.31 $256.5M
    OTRK
    Ontrak
    62.05% -$1.77 $19.4M
  • What do Analysts Say About WGS or OTRK?

    GeneDx Holdings has a consensus price target of $15.25, signalling upside risk potential of 2.14%. On the other hand Ontrak has an analysts' consensus of -- which suggests that it could grow by 117.39%. Given that Ontrak has higher upside potential than GeneDx Holdings, analysts believe Ontrak is more attractive than GeneDx Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    WGS
    GeneDx Holdings
    2 2 0
    OTRK
    Ontrak
    0 0 0
  • Is WGS or OTRK More Risky?

    GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Ontrak has a beta of 2.540, suggesting its more volatile than the S&P 500 by 154.002%.

  • Which is a Better Dividend Stock WGS or OTRK?

    GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Ontrak offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. GeneDx Holdings pays -- of its earnings as a dividend. Ontrak pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios WGS or OTRK?

    GeneDx Holdings quarterly revenues are $76.9M, which are larger than Ontrak quarterly revenues of $2.6M. GeneDx Holdings's net income of -$8.3M is lower than Ontrak's net income of -$5.6M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while Ontrak's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.83x versus 0.63x for Ontrak. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WGS
    GeneDx Holdings
    7.83x -- $76.9M -$8.3M
    OTRK
    Ontrak
    0.63x -- $2.6M -$5.6M
  • Which has Higher Returns WGS or SPOK?

    Spok Holdings has a net margin of -10.81% compared to GeneDx Holdings's net margin of 10.5%. GeneDx Holdings's return on equity of -38.37% beat Spok Holdings's return on equity of 9.13%.

    Company Gross Margin Earnings Per Share Invested Capital
    WGS
    GeneDx Holdings
    62.22% -$0.31 $256.5M
    SPOK
    Spok Holdings
    79.54% $0.18 $156.3M
  • What do Analysts Say About WGS or SPOK?

    GeneDx Holdings has a consensus price target of $15.25, signalling upside risk potential of 2.14%. On the other hand Spok Holdings has an analysts' consensus of -- which suggests that it could fall by -6.43%. Given that GeneDx Holdings has higher upside potential than Spok Holdings, analysts believe GeneDx Holdings is more attractive than Spok Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    WGS
    GeneDx Holdings
    2 2 0
    SPOK
    Spok Holdings
    0 0 0
  • Is WGS or SPOK More Risky?

    GeneDx Holdings has a beta of 0.000, which suggesting that the stock is 100% less volatile than S&P 500. In comparison Spok Holdings has a beta of 0.342, suggesting its less volatile than the S&P 500 by 65.754%.

  • Which is a Better Dividend Stock WGS or SPOK?

    GeneDx Holdings has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Spok Holdings offers a yield of 7.8% to investors and pays a quarterly dividend of $0.31 per share. GeneDx Holdings pays -- of its earnings as a dividend. Spok Holdings pays out 163.68% of its earnings as a dividend.

  • Which has Better Financial Ratios WGS or SPOK?

    GeneDx Holdings quarterly revenues are $76.9M, which are larger than Spok Holdings quarterly revenues of $34.9M. GeneDx Holdings's net income of -$8.3M is lower than Spok Holdings's net income of $3.7M. Notably, GeneDx Holdings's price-to-earnings ratio is -- while Spok Holdings's PE ratio is 21.96x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for GeneDx Holdings is 7.83x versus 2.38x for Spok Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    WGS
    GeneDx Holdings
    7.83x -- $76.9M -$8.3M
    SPOK
    Spok Holdings
    2.38x 21.96x $34.9M $3.7M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

What Companies Are In The VanEck Semiconductor ETF?
What Companies Are In The VanEck Semiconductor ETF?

There’s a lot to love about the VanEck Semiconductor ETF,…

How High Can Palantir Stock Go?
How High Can Palantir Stock Go?

Palantir Technologies (NASDAQ:PLTR) has been one of the undisputed victors…

Will This ETF Beat the Market Over the Next 12 Months?
Will This ETF Beat the Market Over the Next 12 Months?

2024 was another banner year for the US stock market,…

Stock Ideas

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 40x

Buy
56
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 121x

Sell
46
Is MSFT Stock a Buy?

Market Cap: $3.1T
P/E Ratio: 36x

Alerts

Sell
39
DOGZ alert for Jan 4

Dogness (International) [DOGZ] is down 20.52% over the past day.

Buy
66
DMRC alert for Jan 4

Digimarc [DMRC] is up 16.19% over the past day.

Sell
39
MSTR alert for Jan 4

MicroStrategy [MSTR] is up 13.33% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock